In early 2020, communities around the globe saw our "normal" way of life disrupted by the coronavirus pandemic. As the COVID-19 crisis escalated, public health experts advised social distancing, and governments limited group interactions through enforced stay at home orders to prevent cross-contamination.
A New Way of Life
The order of the day has become reducing the number of COVID-19 infections in every country on the planet. Public activities are still being discouraged worldwide in an effort to "level the curve," which would indicate that we are finally slowing the spread of the novel coronavirus that has caused the pandemic. We're not there yet. We need more help from the world of science, and scientific labs have a role to play in helping our communities. Labs can utilize remote blood collection for serology tests that detect SARS-CoV-2 antibodies and get us closer to developing effective vaccines and treatments.
Close monitoring of patients is essential after a kidney transplant to ensure the body is not rejecting its new organ. Kidney transplant patients typically receive therapeutic drugs post-transplant to help their bodies accept the new organ and remain healthy. These therapeutic drugs require monitoring to make sure the patient is receiving the correct dosage for the greatest benefit without negative side effects or complications.
A growing need for patients to take a more proactive role in their health has led to recent trends in "patient-centric medicine" and "telehealth." Healthcare providers who need to monitor patients on a frequent basis, or clinical trial managers who want to recruit participants in remote locations can now use tools and technologies that allow them to conduct virtual check-ins with trial recruits or patients. At-home blood collection with patient-friendly kits is a helpful tool for "going virtual" with patient monitoring and care.
The increasing number of people testing positive for COVID-19 -- the infection caused by the novel coronavirus -- demands easy-to-use sampling kits. Several organizations have been distributing different types of kits to facilitate both rapid testing of active COVID-19 infections and longer-term research studies of antibodies in blood that would help scientists understand immunity to the virus. Kits that can be sent to remote patients from research organizations enable everyone to follow the much-needed social distancing rules recommended by the CDC and other organizations to avoid exposure to contagions.
Neoteryx is thrilled to announce the launch of its new “Microsamplify™ Podcast,” a partner to the blogs we offer on our website. The Microsamplify™ Podcast will amplify the importance of using remote blood collection with precise Volumetric Absorptive Microsampling (VAMS™) technology to modernize research sciences and medicine. We will highlight the many applications of at-home or remote microsampling through a series of conversations with key thought leaders in the industries we serve. Featured guest speakers will include researchers and executives from international pharmaceutical and clinical research organizations, directors from laboratory facilities, providers from healthcare institutions, and coordinators of clinical trials and wellness programs.
At the beginning of April 2020, it was reported by Johns Hopkins University that the number of COVID-19 infections had surpassed the 1 million mark globally, and the number of cases was still rising. In the face of the devastating Coronavirus pandemic that is causing the COVID-19 infections, the race is on to find effective treatments as well as an effective vaccine.